GlaxoSmithKline Pharmaceuticals Overview
- Status
-
Public
- Employees
-
3,840
- Stock Symbol
-
500660
- Investments
-
2
- Share Price
-
$18.11
- (As of Friday Closing)
GlaxoSmithKline Pharmaceuticals General Information
Description
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
- Mumbai
- India
GlaxoSmithKline Pharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.11 | $18.27 | $17.35 - $25.32 | $3.09B | 169M | 4.42K | $1.33 |
GlaxoSmithKline Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 2,839,897 | 3,552,534 | 3,234,216 | 2,665,745 |
| Revenue | 448,619 | 439,959 | 393,226 | 453,815 |
| EBITDA | 106,741 | 104,350 | 57,198 | 44,750 |
| Net Income | 224,663 | 227,456 | 48,138 | 13,118 |
| Total Assets | 611,022 | 424,074 | 415,744 | |
| Total Debt | 0 | 2,648 | 4,715 | 5,548 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
GlaxoSmithKline Pharmaceuticals Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000 | GlaxoSmithKline Pharmaceuticals | Board Member | 000 0000 |
| 00000 000000000 | Self | Board Member | 000 0000 |
| 000000 0000000000 | Self | Board Member | 000 0000 |
GlaxoSmithKline Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
GlaxoSmithKline Pharmaceuticals Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 16-Jul-2015 | 00000 0000 | 00000 | Drug Discovery | |
| Silarus Therapeutics | 22-Sep-2014 | Early Stage VC | 0000 | Drug Discovery |
GlaxoSmithKline Pharmaceuticals Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000000 | 16-Jul-2015 | 00000 00000 00 | 00000 | Completed |
|